Banelli B, , Casciano I, & Romani M: Methylation-independent silencing of the p73 gene in neuroblastoma. Oncogene 19:4553–4556, 2000

Banelli B, Casciano I, Romani M: Methylation-independent silencing of the p73 gene in neuroblastoma. Oncogene 19:4553–4556, 2000)| false
• Search Google Scholar
• Export Citation

Baser ME, & Poussaint TY: Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma. J Med Genet 43:285–287, 2006

Baser ME, Poussaint TY: Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma. J Med Genet 43:285–287, 2006)| false
• Search Google Scholar
• Export Citation

Bello MJ, , de Campos JM, , Vaquero J, , Kusak ME, , Sarasa JL, & Rey JA: High-resolution analysis of chromosome arm 1p alterations in meningioma. Cancer Genet Cytogenet 120:30–36, 2000

Bello MJ, de Campos JM, Vaquero J, Kusak ME, Sarasa JL, Rey JA: High-resolution analysis of chromosome arm 1p alterations in meningioma. Cancer Genet Cytogenet 120:30–36, 2000)| false
• Search Google Scholar
• Export Citation

Boström J, , Meyer-Puttlitz B, , Wolter M, , Blaschke B, , Weber RG, & Lichter P, et al.: Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159:661–669, 2001

Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, : Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159:661–669, 2001)| false
• Search Google Scholar
• Export Citation

Bostrom J, , Muhlbauer A, & Reifenberger G: Deletion mapping of the short arm of chromosome 1 identifies a common region of deletion distal to D1S496 in human meningiomas. Acta Neuropathol 94:479–485, 1997

Bostrom J, Muhlbauer A, Reifenberger G: Deletion mapping of the short arm of chromosome 1 identifies a common region of deletion distal to D1S496 in human meningiomas. Acta Neuropathol 94:479–485, 1997)| false
• Search Google Scholar
• Export Citation

Burbee DG, , Forgacs E, , Zochbauer-Muller S, , Shivakumar L, , Fong K, & Gao B, et al.: Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 93:691–699, 2001

Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, : Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 93:691–699, 2001)| false
• Search Google Scholar
• Export Citation

Corn PG, , Kuerbitz SJ, , van Noesel MM, , Esteller M, , Compitello N, & Baylin SB, et al.: Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation. Cancer Res 59:3352–3356, 1999

Corn PG, Kuerbitz SJ, van Noesel MM, Esteller M, Compitello N, Baylin SB, : Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation. Cancer Res 59:3352–3356, 1999)| false
• Search Google Scholar
• Export Citation

Dammann R, , Li C, , Yoon JH, , Chin PL, , Bates S, & Pfeifer GP: Epigenetic inactivation of a RAS association domain family protein from the lung tumor suppressor locus 3p21.3. Nat Genet 25:315–319, 2000

Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP: Epigenetic inactivation of a RAS association domain family protein from the lung tumor suppressor locus 3p21.3. Nat Genet 25:315–319, 2000)| false
• Search Google Scholar
• Export Citation

Dumanski JP, , Carlbom E, , Collins VP, & Nordenskjold M: Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc Natl Acad Sci U S A 84:9275–9279, 1987

Dumanski JP, Carlbom E, Collins VP, Nordenskjold M: Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc Natl Acad Sci U S A 84:9275–9279, 1987)| false
• Search Google Scholar
• Export Citation

Herman JG, & Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042–2054, 2003

Herman JG, Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042–2054, 2003)| false
• Search Google Scholar
• Export Citation

Hibi K, , Robinson CR, , Booker S, , Wu L, , Hamilton SR, & Sidransky D, et al.: Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res 58:1405–1407, 1998

Hibi K, Robinson CR, Booker S, Wu L, Hamilton SR, Sidransky D, : Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res 58:1405–1407, 1998)| false
• Search Google Scholar
• Export Citation

Horiguchi K, , Tomizawa Y, , Tosaka M, , Ishiuchi S, , Kurihara H, & Mori M, et al.: Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors. Oncogene 22:7862–7865, 2003

Horiguchi K, Tomizawa Y, Tosaka M, Ishiuchi S, Kurihara H, Mori M, : Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors. Oncogene 22:7862–7865, 2003)| false
• Search Google Scholar
• Export Citation

Ichimiya S, , Nimura Y, , Kageyama H, , Takada N, , Sunahara M, & Shishikura T, et al.: p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene 18:1061–1066, 1999

Ichimiya S, Nimura Y, Kageyama H, Takada N, Sunahara M, Shishikura T, : p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene 18:1061–1066, 1999)| false
• Search Google Scholar
• Export Citation

Issa JP: CpG island methylator phenotype in cancer. Nat Rev Cancer 4:988–993, 2004

Issa JP: CpG island methylator phenotype in cancer. Nat Rev Cancer 4:988–993, 2004)| false
• Search Google Scholar
• Export Citation

Jones PA, & Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415–428, 2002

Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415–428, 2002)| false
• Search Google Scholar
• Export Citation

Kaghad M, , Bonnet H, , Yang A, , Creancier L, , Biscan JC, & Valent A, et al.: Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809–819, 1997

Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, : Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809–819, 1997)| false
• Search Google Scholar
• Export Citation

Kawano S, , Miller CW, , Gombart AF, , Bartram CR, , Matsuo Y, & Asou H, et al.: Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation. Blood 94:1113–1120, 1999

Kawano S, Miller CW, Gombart AF, Bartram CR, Matsuo Y, Asou H, : Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation. Blood 94:1113–1120, 1999)| false
• Search Google Scholar
• Export Citation

Kim ST, , Lim DS, , Canman CE, & Kastan MB: Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem 274:37538–37543, 1999

Kim ST, Lim DS, Canman CE, Kastan MB: Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem 274:37538–37543, 1999)| false
• Search Google Scholar
• Export Citation

Lee JY, , Finkelstein S, , Hamilton RL, , Rekha R, , King JT Jr, & Omalu B: Loss of heterozygosity analysis of benign, atypical, and ana-plastic meningiomas. Neurosurgery 55:1163–1173, 2004

Lee JY, Finkelstein S, Hamilton RL, Rekha R, King JT Jr, Omalu B: Loss of heterozygosity analysis of benign, atypical, and ana-plastic meningiomas. Neurosurgery 55:1163–1173, 2004)| false
• Search Google Scholar
• Export Citation

Lekanne Deprez RH, , Bianchi AB, , Groen NA, , Seizinger BR, , Hagemeijer A, & van Drunen E, et al.: Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54:1022–1029, 1994

Lekanne Deprez RH, Bianchi AB, Groen NA, Seizinger BR, Hagemeijer A, van Drunen E, : Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54:1022–1029, 1994)| false
• Search Google Scholar
• Export Citation

Lomas J, , Aminoso C, , Gonzalez-Gomez P, , Eva Alonso M, , Arjona D, & Lopez-Marin I, et al.: Methylation status of TP73 in meningiomas. Cancer Genet Cytogenet 148:148–151, 2004

Lomas J, Aminoso C, Gonzalez-Gomez P, Eva Alonso M, Arjona D, Lopez-Marin I, : Methylation status of TP73 in meningiomas. Cancer Genet Cytogenet 148:148–151, 2004)| false
• Search Google Scholar
• Export Citation

Lomas J, , Bello MJ, , Arjona D, , Gonzalez-Gomez P, , Alonso ME, & de Campos JM, et al.: Analysis of p73 gene in meningiomas with deletion at 1p. Cancer Genet Cytogenet 129:88–91, 2001

Lomas J, Bello MJ, Arjona D, Gonzalez-Gomez P, Alonso ME, de Campos JM, : Analysis of p73 gene in meningiomas with deletion at 1p. Cancer Genet Cytogenet 129:88–91, 2001)| false
• Search Google Scholar
• Export Citation

Maher EA, , Furnari FB, , Bachoo RM, , Rowitch DH, , Louis DN, & Cavenee WK, et al.: Malignant glioma: genetics and biology of a grave matter. Genes Dev 15:1311–1333, 2001

Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, : Malignant glioma: genetics and biology of a grave matter. Genes Dev 15:1311–1333, 2001)| false
• Search Google Scholar
• Export Citation

Meese E, , Blin N, & Zang KD: Loss of heterozygosity and the origin of meningioma. Hum Genet 77:349–351, 1987

Meese E, Blin N, Zang KD: Loss of heterozygosity and the origin of meningioma. Hum Genet 77:349–351, 1987)| false
• Search Google Scholar
• Export Citation

Menon AG, , Rutter JL, , von Sattel JP, , Synder H, , Murdoch C, & Blumenfeld A, et al.: Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative ‘tumor progression' locus. Oncogene 14:611–616, 1997

Menon AG, Rutter JL, von Sattel JP, Synder H, Murdoch C, Blumenfeld A, : Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative ‘tumor progression' locus. Oncogene 14:611–616, 1997)| false
• Search Google Scholar
• Export Citation

Modha A, & Gutin PH: Diagnosis and treatment of atypical and ana-plastic meningiomas: a review. Neurosurgery 57:538–550, 2005

Modha A, Gutin PH: Diagnosis and treatment of atypical and ana-plastic meningiomas: a review. Neurosurgery 57:538–550, 2005)| false
• Search Google Scholar
• Export Citation

Papi L, , De Vitis LR, , Vitelli F, , Ammannati F, , Mennonna P, & Montali E, et al.: Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Hum Genet 95:347–351, 1995

Papi L, De Vitis LR, Vitelli F, Ammannati F, Mennonna P, Montali E, : Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Hum Genet 95:347–351, 1995)| false
• Search Google Scholar
• Export Citation

Piaskowski S, , Rieske P, , Szybka M, , Wozniak K, , Bednarek A, & Pluciennik E, et al.: GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis. Cancer Genet Cytogenet 162:63–67, 2005

Piaskowski S, Rieske P, Szybka M, Wozniak K, Bednarek A, Pluciennik E, : GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis. Cancer Genet Cytogenet 162:63–67, 2005)| false
• Search Google Scholar
• Export Citation

Ruttledge MH, , Andermann AA, , Phelan CM, , Claudio JO, , Han FY, & Chretien N, et al.: Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet 59:331–342, 1996

Ruttledge MH, Andermann AA, Phelan CM, Claudio JO, Han FY, Chretien N, : Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet 59:331–342, 1996)| false
• Search Google Scholar
• Export Citation

Sanson M, & Cornu P: Biology of meningiomas. Acta Neurochir (Wien) 142:493–505, 2000

Sanson M, Cornu P: Biology of meningiomas. Acta Neurochir (Wien) 142:493–505, 2000)| false
• Search Google Scholar
• Export Citation

Versteeg R, , Caron H, , Cheng NC, , van der Drift P, , Slater R, & Westerveld A, et al.: 1p36: every subband a suppressor?. Eur J Cancer 31A:538–541, 1995

Versteeg R, Caron H, Cheng NC, van der Drift P, Slater R, Westerveld A, : 1p36: every subband a suppressor?. Eur J Cancer 31A:538–541, 1995)| false
• Search Google Scholar
• Export Citation

Weber RG, , Bostrom J, , Wolter M, , Baudis M, , Collins VP, & Reifenberger G, et al.: Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci U S A 94:14719–14724, 1997

Weber RG, Bostrom J, Wolter M, Baudis M, Collins VP, Reifenberger G, : Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci U S A 94:14719–14724, 1997)| false
• Search Google Scholar
• Export Citation

Wellenreuther R, , Kraus JA, , Lenartz D, , Menon AG, , Schramm J, & Louis DN, et al.: Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 146:827–832, 1995

Wellenreuther R, Kraus JA, Lenartz D, Menon AG, Schramm J, Louis DN, : Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 146:827–832, 1995)| false
• Search Google Scholar
• Export Citation

Zang KD: Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet 93:207–220, 2001

Zang KD: Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet 93:207–220, 2001)| false
• Search Google Scholar
• Export Citation